Nutrition 21, Inc. - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Nutrition 21, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Nutrition 21, Inc.. The Group's principal activity is to develop market and distribute clinically substantiated nutritional supplements. These products are targeted for age and weight-related health needs, including diabetes, cardiovascular health, obesity, mental health, cognitive function and joint health. The products include Chromax which sells chromium picolinate to vitamin and supplement manufacturers and marketers and directly to retailers for its patented uses in human and animal nutrition products. The Group's trademarks include Chromax, Diachrome, Selenomax, SelenoPure, Zinmax, Zenergen and Magnemax. The Group operates in the United States.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report